Metropolis Healthcare Ltd.

As of March 31, 2026, Metropolis Healthcare Ltd. carries a market capitalization of 89.98B, placing it among publicly traded companies globally. Its enterprise value stands at 90.38B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Metropolis Healthcare Ltd.'s next confirmed earnings release is scheduled for November 10, 2026.

As of March 31, 2026, Metropolis Healthcare Ltd. has 207.33M shares outstanding.

These figures are as of March 31, 2026.

As of March 31, 2026, Metropolis Healthcare Ltd. maintains a current ratio of 1.40, meaning it holds 1.4x the short-term assets needed to cover near-term liabilities.

These figures cover the twelve months ended March 31, 2026.

Over the twelve months ended March 31, 2026, Metropolis Healthcare Ltd. recorded 498.58M in income tax expense.

As of the close on October 22, 2026, Metropolis Healthcare Ltd.'s stock has gained approximately 9.97% over the past 52 weeks. The 50-day moving average sits at 562.81, while the 200-day moving average is 519.71.

As of March 31, 2026, Metropolis Healthcare Ltd. holds 2.03B in cash and equivalents against 2.32B in total debt, resulting in a net debt position of -360.53M. Total book value stands at 15.13B, with working capital of 1.35B providing operational flexibility.

Metropolis Healthcare Ltd.'s most recent stock split took place on March 20, 2026 with a 1:4 split ratio.